A Chronic Obstructive Pulmonary Disease (COPD) Trial Investigating Roflumilast on Safety and Effectiveness in China, Hong Kong and Singapore:
Clinical trial NCT01313494 · COMPLETED
Trial details
- NCT number
- NCT01313494
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2011-03-01
- Primary completion
- 2012-05-01
- Enrollment
- 626
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.